Eiken Chemical Co., Ltd. (JP:4549)
:4549
Want to see JP:4549 full AI Analyst Report?
4549 Stock Chart & Stats
¥2407.00
-¥16.00(-0.73%)
At close: 4:00 PM EST
¥2407.00
-¥16.00(-0.73%)
Day’s Range― - ―
52-Week Range¥1,994.00 - ¥3,500.00
Previous CloseN/A
Volume82.20K
Average Volume (3M)72.32K
Market Cap
¥90.37B
Enterprise Value¥94.22B
Total Cash (Recent Filing)¥4.67B
Total Debt (Recent Filing)¥3.00B
Price to Earnings (P/E)23.5
Beta0.62
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.31%
Share Statistics
EPS (TTM)68.66
Shares Outstanding34,541,440
10 Day Avg. Volume81,940
30 Day Avg. Volume72,320
Financial Highlights & Ratios
PEG Ratio0.37
Price to Book (P/B)2.29
Price to Sales (P/S)2.40
P/FCF Ratio-58.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)91.9
Revenue Forecast (FY)¥43.56B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a large equity base provide durable financial flexibility, allowing the company to fund R&D, maintain reagent supply chains, or absorb cyclical test-volume declines without forcing distressed asset sales. This cushion supports multi-month to multi-year strategic investments and risk management.
Recurring Consumables Revenue ModelRevenue driven by recurring reagent/test kit consumption and installed analyzers creates predictable, repeatable cash inflows tied to test volumes. That consumables-driven model sustains unit economics over time, supports margin recovery if volumes rise, and underpins customer stickiness versus one-time sales.
Proprietary Molecular (LAMP) TechnologyOwning LAMP technology and a diversified IVD product lineup is a durable competitive advantage: it enables differentiated assays, licensing or partnerships, and expansion into molecular testing segments that have structural growth. This IP can support higher-margin products and defend commercial relationships.
Bears Say
Sustained Margin CompressionMaterial margin deterioration versus prior years suggests persistent pricing pressure, adverse product mix, or rising input costs. Lower margins reduce retained earnings available for capex, R&D, or dividends and make it harder to fund growth initiatives without higher volumes or structural cost cuts over the medium term.
Negative Free Cash Flow In 2026Negative FCF signals weakened cash conversion and potential working-capital strain or elevated investments. Even with low leverage, recurring negative FCF can force the firm to draw on cash reserves or increase debt to fund operations or capex, limiting strategic optionality and increasing financing risk over the coming quarters.
Weak Top-line RecoveryA shallow recovery after a significant revenue drop indicates structural demand or competitive issues limiting growth. Slow top-line expansion constrains operating leverage, delays margin normalization, and may imply the company needs new products, markets, or partnerships to regain prior scale and profitability over the medium term.
Eiken Chemical Co., Ltd. News
4549 FAQ
What was Eiken Chemical Co., Ltd.’s price range in the past 12 months?
Eiken Chemical Co., Ltd. lowest stock price was ¥1994.00 and its highest was ¥3500.00 in the past 12 months.
What is Eiken Chemical Co., Ltd.’s market cap?
Eiken Chemical Co., Ltd.’s market cap is ¥90.37B.
When is Eiken Chemical Co., Ltd.’s upcoming earnings report date?
Eiken Chemical Co., Ltd.’s upcoming earnings report date is Jul 29, 2026 which is in 53 days.
How were Eiken Chemical Co., Ltd.’s earnings last quarter?
Eiken Chemical Co., Ltd. released its earnings results on May 12, 2026. The company reported -¥0.42 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.42.
Is Eiken Chemical Co., Ltd. overvalued?
According to Wall Street analysts Eiken Chemical Co., Ltd.’s price is currently Overvalued.
Does Eiken Chemical Co., Ltd. pay dividends?
Eiken Chemical Co., Ltd. pays a Semiannually dividend of ¥29 which represents an annual dividend yield of 2.31%. See more information on Eiken Chemical Co., Ltd. dividends here
What is Eiken Chemical Co., Ltd.’s EPS estimate?
Eiken Chemical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eiken Chemical Co., Ltd. have?
Eiken Chemical Co., Ltd. has 34,541,440 shares outstanding.
What happened to Eiken Chemical Co., Ltd.’s price movement after its last earnings report?
Eiken Chemical Co., Ltd. reported an EPS of -¥0.42 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.793%.
Which hedge fund is a major shareholder of Eiken Chemical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4549
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.
Technical Analysis
PHC Holdings Corp.
―
Techno Medica Co., Ltd.
―
Rion Co., Ltd.
―
Nihon Kohden Corporation
―
Options Prices
Currently, No data available
---